Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
Clinical trial NCT03172624 · COMPLETED
Trial details
- NCT number
- NCT03172624
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2024-12-18
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.